Our data point in particular to p39 overexpression and Rb phosphorylation on serine 249 as biomarkers that could refine current methods used for NSCLC grading, histologic sub-classification and assessment of metastatic potential. This evidence concerns the gene CDK5R2 and non-small cell lung carcinoma.